Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics

Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in plasma of GBM patients, we performed quantitative comparisons of the plasma proteomes of GBM patients (n = 14) and healthy controls (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyauchi, Eisuke, Furuta, Takuya, Ohtsuki, Sumio, Tachikawa, Masanori, Uchida, Yasuo, Sabit, Hemragul, Obuchi, Wataru, Baba, Tomoko, Watanabe, Michitoshi, Terasaki, Tetsuya, Nakada, Mitsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841790/
https://www.ncbi.nlm.nih.gov/pubmed/29513714
http://dx.doi.org/10.1371/journal.pone.0193799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841790/
https://www.ncbi.nlm.nih.gov/pubmed/29513714
http://dx.doi.org/10.1371/journal.pone.0193799

Ejemplares similares